Avalyn Pharma Inc. · NASDAQ:AVLN
Perceptive Advisors LLC reported a 6.00% stake in Avalyn Pharma Inc. (Schedule 13G)
Event Apr 30, 2026 · Filed May 7, 2026
Perceptive Advisors LLC reported a 6.00% stake in Avalyn Pharma Inc., 2,675,296 shares, as a passive investor on Apr 30, 2026. Filed May 7, 2026 (Schedule 13G).
- Stake
- 6.00%
- Shares
- 2,675,296
- Intent
- Passive
- What changed
- Crossed above 5%
- Filed together
- 4 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Perceptive Advisors LLC | 6.00% | 2,675,296 |
| Joseph Edelman | 6.00% | 2,675,296 |
| Perceptive Life Sciences Master Fund, Ltd. | 1.00% | 425,000 |
| Perceptive Xontogeny Venture Fund II, L.P | 5.10% | 2,250,296 |
Source
Related
- Avalyn Pharma Inc.
- Perceptive Advisors LLC
- Avalyn Pharma Inc. shareholders
- Schedule 13G · Novo Holdings A/S · Aug 14, 2026
- Schedule 13G · Norwest Venture Partners XV, LP · Aug 11, 2026
- Schedule 13G/A · FMR LLC · Aug 6, 2026
- Schedule 13D · Montanova Capital, LLC · May 8, 2026
- Schedule 13D · SR One Capital Management, LLC · May 8, 2026